Registered Members Login:
   
Forgotten Your Details? Click Here To Recover +
Welcome To The ShareCafe Community - Talk Shares And Take Stock With Smart Investors - New Here? Click To Register >


xlnja
Posted on: Dec 14 2019, 03:51 AM


Group: Member
Posts: 69

I understand PW's desire to keep everything "in house". That kind of thinking goes with his background in medicine where you have to become an expert yourself instead of relying on external resources. I'm speaking in terms of their practice of having existing employees handle the rollouts, submissions, etc. While this approach keeps costs down and increases employee knowledge and value, it is also very slow. Can you imagine trying to figure out the rules and regulations for all the EU countries and the U.S.? Without experience in those areas, you figure out things as you go and often don't know what you don't know. If we had an unlimited amount of time to do all the rollouts without competition and could wait 50 years for returns, this might be fine, but speed is needed now to capitalize as soon as possible. Get some experts to move this thing along.
  Forum: By Share Code

xlnja
Posted on: Dec 6 2019, 08:17 AM


Group: Member
Posts: 69

Apparently some people weren't fooled by LH. No mention of LH's doomsday prophecies here...

https://au.finance.yahoo.com/news/why-clinu...-041041261.html
  Forum: By Share Code

xlnja
Posted on: Dec 5 2019, 09:38 AM


Group: Member
Posts: 69

Although I welcome alternative viewpoints to keep myself "level headed", it became obvious that something wasn't right when LH kept on pushing the doomsday narrative for over a week. Would someone who claims to be a substantial shareholder do this knowing that his comments, valid or not, could substantially cut into his own profits? I don't think so.
  Forum: By Share Code

xlnja
Posted on: Nov 29 2019, 10:25 AM


Group: Member
Posts: 69

By the way, any word from Mr Homm since the recent MT-7117 report?
  Forum: By Share Code

xlnja
Posted on: Nov 28 2019, 02:45 AM


Group: Member
Posts: 69

Has anyone asked Clinuvel management about MT-7117 and their strategy? (I don't know if they could or would give any information.)
  Forum: By Share Code

xlnja
Posted on: Nov 27 2019, 02:58 AM


Group: Member
Posts: 69

QUOTE
What about Scenesse in (micro needle patch) formulation.


Given Clinuvel's extremely slow pace, I don't see a micro needle patch of Scenesse coming any time soon.

Some other concerns...

  • *The MT-7117 results were released one week prior to the Clinuvel AGM. Why did PW not address this existential threat during the presentation or during questions? Surely, management has been aware of MT-7117 for some time...right?! Wouldn't institutional investors have already asked about this? Clinuvel should have at least stated a plan to address the threat.
  • *What will be the price for MT-7117? Clinuvel has only one approved drug priced at $15k USD per implant. Mitsubishi Tanabe has many drugs in its portfolio and can sell MT-7117 at whatever price point is necessary to take all the market share from Clinuvel. Preference for pill, implant, or patch won't matter if Tanabe is selling MT-7117 at $100/pill. It will be a no brainer. Clinuvel will be forced to drop the price of Scenesse to unsustainable levels.


I am not trying to be negative on the stock (I have my life savings in it). I had anticipated a year of smooth sailing after FDA approval that now has been shortened to a month. Perhaps MT-7117 is the cause of the continuing slump in the share price, not day-trading shorters. One thing is for sure...PW needs to lift the gag order and start communicating with investors regularly to stop the bleeding.
  Forum: By Share Code

xlnja
Posted on: Nov 26 2019, 05:51 PM


Group: Member
Posts: 69

Assuming MT-7117 is just as safe and effective, I don't see why anyone would take an implant over a pill.

Before FDA approval, there was a small risk that Scenesse would not be approved, and I was willing to take that risk. The risk to the stock before/after MT-7117 results is much greater. I'll just need to reevaluate my exposure.
  Forum: By Share Code

xlnja
Posted on: Nov 26 2019, 05:37 PM


Group: Member
Posts: 69

Positive results for MT-7117 in early 2020 would be very damaging to CUV, and final approval 2-3 years later would put the nail in the coffin for Scenesse.

This is like a bad dream... We finally get FDA approval in October and then 1 month later the bombshell MT-7117 report lands. Yes, there are still a lot of "ifs", but MT-7117 has just ramped up the investment risk in CUV just when I was finally looking forward to reduced risk. SMH
  Forum: By Share Code

xlnja
Posted on: Nov 26 2019, 04:21 AM


Group: Member
Posts: 69

When is the earliest that MT-7117 could be approved? 2021? 2022?
  Forum: By Share Code

xlnja
Posted on: Nov 26 2019, 03:15 AM


Group: Member
Posts: 69

QUOTE
I can honestly say (for what it’s worth) that confusion and frustration is growing at a time when I truely thought we would be shifting up into a higher gear and celebrating, not idling in neutral and cursing.


My sentiment exactly. It has me rethinking my "all-in" investment. I didn't expect this AFTER FDA approval.
  Forum: By Share Code

xlnja
Posted on: Nov 25 2019, 09:43 AM


Group: Member
Posts: 69

Did anyone ask about competitors during the AGM? They seem to have come out of nowhere and appear to be a real threat.
  Forum: By Share Code

xlnja
Posted on: Nov 22 2019, 04:32 AM


Group: Member
Posts: 69

QUOTE
Striking how threats to Clinuvel have suddenly (seemingly) manifested themselves


It seems that way to me too.

I always intended to give the stock a year after FDA approval before I start selling, but my greatest fear is that some competitor comes along before then and pulls the rug out from under us. Being that I am so heavily invested in this stock, such a scenario would be devastating.

I was hoping that management had a plan to "open the flood gates" after FDA approval. Apparently, that is not the case. Instead, they are moving at their typical glacial pace.

Ironically, I feel more nervous now about the investment risk than I did before FDA approval because of the "business-as-usual" AGM presentation.
  Forum: By Share Code

xlnja
Posted on: Nov 12 2019, 11:47 PM


Group: Member
Posts: 69

Yes, liquidity and broadening the investor base should be the focus.
  Forum: By Share Code

xlnja
Posted on: Nov 12 2019, 10:38 AM


Group: Member
Posts: 69

All the more reason PW needs to get f!@#ing moving on U.S. sales. We all haven't waited this many years for FDA approval to see our investment evaporate from real competition.
  Forum: By Share Code

xlnja
Posted on: Oct 17 2019, 07:58 AM


Group: Member
Posts: 69

I wonder how much of the stock churn is coming from us on this board. Half of today's CLVLY activity was due to my own orders. We need a NASDAQ listing to get a lot more new blood into this stock before it's going to skyrocket.
  Forum: By Share Code

xlnja
Posted on: Oct 10 2019, 11:38 PM


Group: Member
Posts: 69

...here is the approval letter...

Attached File  210797Orig1s000ltr.pdf ( 1.34MB ) Number of downloads: 119
  Forum: By Share Code

xlnja
Posted on: Oct 10 2019, 11:36 PM


Group: Member
Posts: 69

Scenesse is now showing up on the FDA site

https://www.accessdata.fda.gov/scripts/cder/daf/

  Forum: By Share Code

xlnja
Posted on: Oct 9 2019, 04:08 AM


Group: Member
Posts: 69

Wow, just over 15 years. A long wait that has finally paid off!
  Forum: By Share Code

xlnja
Posted on: Oct 9 2019, 03:53 AM


Group: Member
Posts: 69

How about a free sample for all of us long-term shareholders :-)
  Forum: By Share Code

xlnja
Posted on: Oct 9 2019, 03:50 AM


Group: Member
Posts: 69

My first CLVLY purchase: 17-SEP-2009
FDA Approval: 08-OCT-2019

Just over 10 years waiting for this day. Congratulations everyone!! Now just need to decide when to sell :-)
  Forum: By Share Code

xlnja
Posted on: Oct 9 2019, 12:25 AM


Group: Member
Posts: 69

I think it's likely they already have the information. They have been in constant contact with the FDA, so they at least have a good indication of the outcome. Also, the CEO announcement yesterday seems to suggest they already know it's going to be approved.
  Forum: By Share Code

xlnja
Posted on: Jul 22 2019, 09:01 AM


Group: Member
Posts: 69

Yes, when to divest is the tricky decision. If we end up having the conversation, "why would you sell a 200 usd stock when it’s worth 500 usd", I'll be more than happy to be all out at $200.
  Forum: By Share Code

xlnja
Posted on: Jun 22 2019, 10:02 AM


Group: Member
Posts: 69

The FDA had to approve the drug or no doubt some lunatic group would have screamed sexism for not approving a drug designed to help women's libidos.
  Forum: By Share Code

xlnja
Posted on: Jun 20 2019, 03:43 AM


Group: Member
Posts: 69

Regarding takeover bids...does anyone have an idea on the average timeline from announcement to execution? I assume that the earliest we might see a takeover bid is in October after FDA approval. Retrophin's suggested timeline was roughly 1 1/2 months from announcement to execution ("17 July 2014" to "Late August") Retrophin Announcement

So, that might put an execution at the end of November, but I don't know if Retrophin's timeline is the norm. Given the proximity to the end of the year, the time of execution could have a major impact on capital gains tax.
  Forum: By Share Code

xlnja
Posted on: Jun 1 2019, 06:42 AM


Group: Member
Posts: 69

I agree. Being under the radar, Clinuvel has practically been impervious to market swings.
  Forum: By Share Code

xlnja
Posted on: Jun 1 2019, 06:39 AM


Group: Member
Posts: 69

It almost makes you wish there is a takeover post FDA approval so that you don't have the nagging conundrum..."if only I had sold/held". I say ALMOST. I would still like to see the company grow to its full potential.
  Forum: By Share Code

xlnja
Posted on: May 29 2019, 05:16 PM


Group: Member
Posts: 69

I'm glad you brought up this topic. I've been thinking about this on a daily basis lately, in addition to how to best reduce my holdings in CLVLY and diversify (It's unwise to have 90% of your holdings in one stock, but when that stock has a real chance of producing lottery-like winnings, it's a risk I'll take).

I too have been "coasting" for the last few months in anticipation of the FDA decision. I work as an independent contractor. My last contract ended four months ago, and I have barely looked for the next contract. I have never been unemployed this long in my life, but we live in unusual circumstances as substantial Clinuvel stockholders. During this time, I have gone back and forth thinking whether to retire or not. As others have said, if you do retire, you need to have a plan of what to do with your life to have a purpose. I am leaning towards staying employed at least on a part-time basis because I like what I do and also as a hedge against any possible future financial calamities. Of course, all of this hinges on July 8th (or sooner), but best to have the scenarios planned out before then.
  Forum: By Share Code

xlnja
Posted on: May 29 2019, 04:20 PM


Group: Member
Posts: 69

It is possible that the shorters are also long on CUV to hedge their position against a possible FDA rejection. While they would not benefit from the immediate bump in the stock post FDA approval, they also wouldn't lose anything if there is a rejection.
  Forum: By Share Code

xlnja
Posted on: May 11 2019, 08:22 AM


Group: Member
Posts: 69

Think I found the answer...

https://www.investopedia.com/ask/answers/08...nyse-nasdaq.asp

QUOTE
While a lot of fanfare may occur when a stock is newly listed on an exchange, especially the NYSE, a new initial public offering (IPO) is not carried out. Instead, the stock simply goes from being traded through the OTC market to being traded on the exchange.

However, the stock symbol may change. A stock that moves from the OTC to Nasdaq often keeps its symbol. Contrarily, a stock that moves to the NYSE often must change its symbol, due to NYSE regulations that limit stock symbols to three letters. The OTC and Nasdaq both allow up to five letters.
  Forum: By Share Code

xlnja
Posted on: May 11 2019, 07:51 AM


Group: Member
Posts: 69

With a NASDAQ listing, will the CLVLY ADRs all be converted to the new NASDAQ security? Or will they both continue to be traded?
  Forum: By Share Code

xlnja
Posted on: Apr 27 2019, 02:46 PM


Group: Member
Posts: 69

For us long timers, the one consolation should the shit hit the fan and FDA approval not be granted is that our low average sp means we can handle a fairly large sp decrease before we're in the red. Fingers crossed.
  Forum: By Share Code

xlnja
Posted on: Apr 9 2019, 03:27 AM


Group: Member
Posts: 69

Regarding today's FDA target date for communicating labelling and post-marketing requirements...do we expect any such communication to be made public by the FDA or Clinuvel?
  Forum: By Share Code

xlnja
Posted on: Apr 1 2019, 06:43 AM


Group: Member
Posts: 69

I agree. 30x is a pie-in-the-sky figure, but even if it only goes to 5x, I'd be more than happy.
  Forum: By Share Code

xlnja
Posted on: Mar 27 2019, 08:13 AM


Group: Member
Posts: 69

Collaborating with Congressman Hank Johnson?! blink.gif I really have to hold my tongue about that guy. There's got to be a better sponsor than him, but whatever works I suppose.
  Forum: By Share Code

xlnja
Posted on: Mar 14 2019, 02:24 PM


Group: Member
Posts: 69

QUOTE
I feel those shorting really don't understand the full history of this company when they just see a parabolic SP rise that is 'due for a correction' when the shares are so tightly held by many LTers who are here at a minimum until the FDA decision


Exactly...the bulk of shares are held by institutions and LTers who are not selling anything until at least the FDA decision. New buyers who want to acquire any sizable amount of shares are going to drive up the price quickly. There is huge upward pressure on the stock. Us LTers are finally reaping the rewards of the massive amount of risk we took on over these years.
  Forum: By Share Code

xlnja
Posted on: Mar 12 2019, 02:43 PM


Group: Member
Posts: 69

The worst case would be a takeover resulting in the recognition of all the capital gains in one year. I am hoping to spread the gains over 2-3 years. Since many of us are sitting on "lottery size" gains, moving to a no-tax state like NV, TX, or FL could literally save hundreds of thousands in taxes. I guess you could ask yourself...if someone offered you $300k to move to a no-tax state for a year...would you do it?
  Forum: By Share Code

xlnja
Posted on: Mar 7 2019, 07:26 AM


Group: Member
Posts: 69

The AUD/USD exchange rate is reflected in the ADR price. I've been monitoring CUV converted to USD against CLVLY for many years, and the price moves in lock step with the exchange rate factored in.
  Forum: By Share Code

xlnja
Posted on: Mar 7 2019, 05:27 AM


Group: Member
Posts: 69

The exchange rate drop has been annoying. The bulk of my shares were purchased with an average AUD rate of .90...so the current AUD rate of .70 represents an over 20% drop in the ADR price due to exchange rate variance. grrr.gif
  Forum: By Share Code

xlnja
Posted on: Mar 6 2019, 01:12 PM


Group: Member
Posts: 69

This is what I would like to know as well..."what would happen to current US holders of the ADRs if NASDAQ listing happened". I assume ADRs would be converted to NASDAQ shares. Is that correct?
  Forum: By Share Code

xlnja
Posted on: Mar 6 2019, 07:08 AM


Group: Member
Posts: 69

It's like a runaway freight train. Assuming inclusion in the ASX200 and no issues with the FDA Apr 8 labelling communication, I don't see any reason for a significant pullback up to the Jul 8 PDUFA Date. I wouldn't mind a small pullback though to buy some more :-)
  Forum: By Share Code

xlnja
Posted on: Feb 20 2019, 12:26 PM


Group: Member
Posts: 69

If it were like the old days (i.e., no news, no hard timelines/dates), I would expect another 15-20% drop, however now that we have a fixed FDA approval date, I'm not so sure. It sucks because I was in the process of transferring funds to purchase my last chunk of shares at the time of the Jan 10th jump. I believe johnnytech had the same issue. I've still got my order out there waiting for a drop, but who knows? On the positive side, the continued stock price increase is great news for everyone's current holdings.
  Forum: By Share Code

xlnja
Posted on: Feb 15 2019, 09:27 AM


Group: Member
Posts: 69

I've noticed the same thing. I have a spreadsheet with CLVLY and CUV converted to USD. The spread between the prices on close/open has increased a little over the last few months.
  Forum: By Share Code

xlnja
Posted on: Feb 1 2019, 11:24 AM


Group: Member
Posts: 69

I agree. It's better to hear all opinions than only those we want to hear. Echo chambers are not helpful.
  Forum: By Share Code

xlnja
Posted on: Sep 28 2018, 10:12 AM


Group: Member
Posts: 69

Once the SP hits $40 AUD, I plan to sell enough shares to cover the total cost basis of all my shares plus a small return. I started investing nearly 10 years ago, so fortunately my cost basis is low and wouldn't require selling very many shares. If the shit should hit the fan afterwards, at least I will have recovered my initial investment.

After that initial sale, I will likely start liquidating the remaining shares evenly over 2-3 years (still deciding on that range).
  Forum: By Share Code

xlnja
Posted on: Sep 1 2018, 07:09 AM


Group: Member
Posts: 69

Isn't it great that many of us find ourselves in this situation of huge gains that require serious consideration of our tax situation?! :-)

Here is a good explanation I found on Nerdwallet (link)...

"Long-term capital gains (LTCGs) are a separate rate you pay on investment property you have held for at least 1 year + 1 day. While they are taxed separately, the rate is dependent on your ordinary income tax bracket. If your tax bracket including the gain is 10% or 15%, then your LTCG rate is zero. If your gains push you into the 25%, 28%, 33%, or 35% tax bracket, you will pay 15% on the gains. Beyond that, you will pay the top LTCG rate of 20%.

Short-term capital gains are taxed as ordinary income, period."


I normally do my own taxes, but I will be employing a Tax Consultant before I sell these shares.

Good luck!
  Forum: By Share Code

xlnja
Posted on: May 23 2018, 02:41 AM


Group: Member
Posts: 69

Looks like bad news from NICE. This is the only article I have found on the subject, but it was posted today...

http://www.pmlive.com/pharma_news/daily_br...nd_more_1236401

"NICE rejects Clinuvel’s rare photosensitivity disease treatment

England’s cost effectiveness watchdog has given a ‘final evaluation determination’ (FED) for Clinuvel’s rare disease treatment Scenesse.

The drug is a treatment for patients with erythropoietic protoporphyria (EPP), a condition in which exposure to light causes painful and debilitating reactions in the body.

Scenesse (afamelanotide) has not been launched in the UK, but the company has stated that the cost of an implant will be £12,020 (excluding VAT).

The marketing authorisation recommends an implant is administered every two months before expected, and during increased, sunlight exposure from spring to early autumn, and recommends a maximum of four implants per year.

NICE’s Highly Specialised Technologies (HST) committee concluded that overall the drug “doesn’t appear to provide value for money” as a highly specialised service, and cannot be recommended for routine NHS funding.

The appraisal is one of 10 NICE highly specialised drug appraisals in development NICE, with a further three proposed."


The NICE website "Final evaluation determination document" also confirms the ruling...

https://www.nice.org.uk/guidance/gid-hst100...nation-document
  Forum: By Share Code

xlnja
Posted on: Mar 1 2018, 05:44 AM


Group: Member
Posts: 69

The new logo is a busy mess, but if they're going to put it up on the website, at least upload a high-res version. Having a low-res version up there screams amateur web design. It looks really bad on mobile devices.
  Forum: By Share Code

xlnja
Posted on: Jul 16 2017, 03:54 AM


Group: Member
Posts: 69

Tell me about it. I've held CLVLY for eight years now, and I tripled my position after the EMA approval. If I had put that money in Tesla or Amazon, I'd be a millionaire by now. Instead, I'm continuing the endless wait for this stock to make a break out.
  Forum: By Share Code

xlnja
Posted on: Jul 8 2017, 11:11 AM


Group: Member
Posts: 69

They haven't updated the web page in a long time. It says at the bottom..."Date of last update: September 2008". Still, you'd think they'd be excited enough about Scenesse to update the page.
  Forum: By Share Code

xlnja
Posted on: Jan 10 2017, 12:17 PM


Group: Member
Posts: 69

Accounting terminology...it means payment on invoices is due 30 days from receipt.
  Forum: By Share Code

xlnja
Posted on: Mar 18 2016, 06:54 AM


Group: Member
Posts: 69

"Back in black, I hit the sack, I've been too long I'm glad to be back..."

Finally!! CLVLY closes at $2.78, and my average holdings are back in black. Now, let's keep this train rolling!! :-)
  Forum: By Share Code

xlnja
Posted on: Mar 10 2016, 01:32 AM


Group: Member
Posts: 69

This stock has never followed the market, which sometimes has been a good thing. I could always count on my CLVLY holdings remaining relatively stable when the market crashed. There is just far too little awareness of this stock for it to follow technical analysis.
  Forum: By Share Code

xlnja
Posted on: Dec 16 2015, 12:59 AM


Group: Member
Posts: 69

I wonder if there is any precedent of a pharma having its stock price steadily decline by half after its drug is approved...

CLVLY Chart

This has to be a rare occurrence. It's just our luck we get to go along for this nightmarish ride. In the meantime, I still believe in the company. What else can I do with 10s of thousands of shares that are nearly impossible to unload without a loss? Maybe one day, we will all look back on this time and laugh...I hope.
  Forum: By Share Code

xlnja
Posted on: Nov 28 2015, 03:35 PM


Group: Member
Posts: 69

Wow, how did you catch that? It's only visible for like a 10th of second.
  Forum: By Share Code

xlnja
Posted on: Nov 25 2015, 05:21 AM


Group: Member
Posts: 69

Next AGM is too far away. Waiting another year for results is ridiculous. I've been waiting for an ROI on this stock since 2009, and many here for longer than that.

I'm hoping that after revenue starts flowing from EU that a big pharma comes in and makes a reasonable buy-out offer of at least $6 AUD.
  Forum: By Share Code

xlnja
Posted on: Nov 14 2015, 12:11 PM


Group: Member
Posts: 69

Can we please get a decent return on this stock, or at least get in the black before this global turmoil brings down the economy and CUV along with it!? We've waited too long to have the stock sabotaged by global turmoil. Time is of the essence here!
  Forum: By Share Code

xlnja
Posted on: Aug 21 2015, 01:28 PM


Group: Member
Posts: 69

It better get back up to at least $3 USD. That's break-even for me after my post-approval purchases ratcheted up my cost basis. Imagine that, six years in this stock with an approved drug, and I'm not at break-even, actually 35% in the red!

I am also worried about the global stock markets. We are teetering on a possible crash. Time is of the essence. Although CLVLY has typically been immune to market trends, it would be just our luck if we hear good news in September at the same time that the global markets crash and take the sp with it.
  Forum: By Share Code

xlnja
Posted on: Aug 6 2015, 01:23 PM


Group: Member
Posts: 69

I just saw a TV commercial for Belsomra in the U.S. It's a sleeping aid. The list of possible side effects was so ridiculous that I had to post them here...

BELSOMRA may cause serious side effects that you may not know are happening to you. These side effects include:

*sleepiness during the day
*not thinking clearly
*acting strangely, confused, or upset
*“sleep-walking” or doing other activities when you are asleep like eating, talking, having sex, or driving a car.


So, a drug that can cause you to drive a car while asleep and not even know it the next day gets FDA approval, and yet Scenesse with hardly any side effects has to go through the wringer because, ohhhhhh, it causes tanning. Total bullshit!!
  Forum: By Share Code

xlnja
Posted on: Jul 28 2015, 02:52 PM


Group: Member
Posts: 69

Exactly, it is because of the "Non-communicative attitude of our CEO" PW moves at a snails pace. The momentum behind the post-approval bump has completely eroded, and we are now trading at pre-approval levels. We need a CEO who moves quickly and communicates. What the hell was the company doing all this time before approval? Apparently, nothing. They could have researched and prepared themselves to hit the ground running after approval. Instead, it appears they just started figuring it all out afterwards.

PW's slow and steady approach is killing this stock. There should be frequent updates to hype the progress being made, not silence for 6 months. PW has done us all a disservice. I am currently 10s of thousands in the red on this stock. I know from years of experience that this stock can turn around quickly, but I fear it could go so low that a takeover or privatizing initiative will get approved that will still leave me in the red...and after 6 years in this stock!!
  Forum: By Share Code

xlnja
Posted on: Jul 28 2015, 06:03 AM


Group: Member
Posts: 69

"For those that don't like the current state of affairs, your only recourse is to sell your shareholding."

The problem is that with such a thinly traded stock it is almost impossible to liquidate your holdings without incurring additional losses. I have been increasing my holdings in CLVLY for about 6 years. I now have a very large portion of my savings locked into this stock with no way out until the thing starts trading like a normal company. My cost average was about $1.90 before approval, but now it is much higher given the large purchases I made post-approval, because, after all, everyone expects a company with an approved drug to get a sizeable bump, right!!!? Wrong!!! What a disaster.

I just looked at CLVLY right now, and it is trading at $1.85!! What the hell PW!? Get your sh#t together...communicate, partner with a larger firm, or something. You are in over your head trying to market to the entire EU. You don't have the resources or the know how to do that in a timely manner.
  Forum: By Share Code

xlnja
Posted on: Jul 23 2015, 03:03 AM


Group: Member
Posts: 69

Trading now lower than pre-approval. What the f@#k!!
  Forum: By Share Code

xlnja
Posted on: May 3 2015, 01:44 PM


Group: Member
Posts: 69

It's irritating that the EMA and FDA are even concerned about off-label use. We have a proven drug with a long safety record. They shouldn't deny broad use of a drug because of cosmetic use. As someone with Type 1 skin, I would love to have this drug, and so what if it's for cosmetic reasons. It's BS that these regulators prevent me and others from enjoying these benefits just because they don't like the idea of a tanning drug. Anyway, just venting.
  Forum: By Share Code

xlnja
Posted on: Nov 3 2014, 05:27 AM


Group: Member
Posts: 69

Is there any history of a drug receiving marketing approval and not being ratified? Or is the ratification a foregone conclusion?
  Forum: By Share Code

xlnja
Posted on: Oct 30 2014, 01:51 PM


Group: Member
Posts: 69

I am also feeling extremely frustrated post approval. I started acquiring shares 5 years ago. I doubled my stake in the stock just after approval with shares in the $3-4 range. Now, Clinuvel makes up the largest percentage of my portfolio. I thought for sure the stock would maintain a minimum level of $5, which would give me some comfort that at least I wouldn't lose what I invested. Instead of feeling relaxed post approval, I find myself more stressed with this extremely disappointing post-approval "bump". It sucks!
  Forum: By Share Code

xlnja
Posted on: Oct 29 2014, 05:54 PM


Group: Member
Posts: 69

Yes, 2015. Good! I've held this stock for many years, like most here. No need to delay this payoff any longer.
  Forum: By Share Code

xlnja
Posted on: Oct 29 2014, 05:52 PM


Group: Member
Posts: 69

He originally had 2016, but edited it recently to 2015
  Forum: By Share Code

xlnja
Posted on: Oct 29 2014, 05:46 PM


Group: Member
Posts: 69

Actually, it appears Uhohinc edited his post to now show 2015 (perhaps based on this blog). I hope it is not 2016.
  Forum: By Share Code

xlnja
Posted on: Oct 29 2014, 05:45 PM


Group: Member
Posts: 69

As far as having Scenesse in the major European countries, it sounded to me that he said 2016, which sounds far off. 2016 is also what Uhohinc posted on Google....

https://groups.google.com/forum/#!topic...vel/ku7tkdM-g5w
  Forum: By Share Code

xlnja
Posted on: Oct 29 2014, 05:02 PM


Group: Member
Posts: 69

Is there any history of drugs obtaining approval from the EMA and subsequently not being ratified?

By the way, I am new to this blog. I've held shares for over 5 years and recently started monitoring this blog just prior to the approval. Great advice here and nice to be in company of other long-term investors.
  Forum: By Share Code


Cant find what you are looking for? Show all active topics from the last 3 months


New Posts  New Replies
No New Posts  No New Replies
Hot topic  Hot Topic (New)
No new  Hot Topic (No New)



TERMS OF USE  -  CONTACT ADMIN  -  ADVERTISING